What is Celldex Therapeutics's PP&E (net)?

Celldex Therapeutics (CLDX) reported PP&E (net) of $7.4M in Q1 2026.

How has Celldex Therapeutics's PP&E (net) changed year-over-year?

Celldex Therapeutics's PP&E (net) increased by 60.7% year-over-year, from $4.6M to $7.4M.

What is the long-term trend for Celldex Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Celldex Therapeutics's PP&E (net) has grown at a 6.9% compound annual growth rate (CAGR), from $3.82M to $5.33M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Celldex Therapeutics CLDX PP&E (Net)

PP&E (Net) at other companies

Eli LillyLLY

$26.54B+43.7%

PfizerPFE

$19.4B+5.8%

Rogers CorporationROG

$363.9M-3.1%

AmgenAMGN

$8.22B+23.0%

IncyteINCY

$720.17M-5.9%

AbbVieABBV

$5.69B+8.6%

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's PP&E (net)?: Celldex Therapeutics (CLDX) reported PP&E (net) of $7.4M in Q1 2026.
How has Celldex Therapeutics's PP&E (net) changed year-over-year?: Celldex Therapeutics's PP&E (net) increased by 60.7% year-over-year, from $4.6M to $7.4M.
What is the long-term trend for Celldex Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Celldex Therapeutics's PP&E (net) has grown at a 6.9% compound annual growth rate (CAGR), from $3.82M to $5.33M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.